U.S. flag

An official website of the United States government

NM_005199.5(CHRNG):c.401_402del (p.Pro134fs) AND Autosomal recessive multiple pterygium syndrome

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Apr 15, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000498334.8

Allele description [Variation Report for NM_005199.5(CHRNG):c.401_402del (p.Pro134fs)]

NM_005199.5(CHRNG):c.401_402del (p.Pro134fs)

Gene:
CHRNG:cholinergic receptor nicotinic gamma subunit [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
2q37.1
Genomic location:
Preferred name:
NM_005199.5(CHRNG):c.401_402del (p.Pro134fs)
HGVS:
  • NC_000002.12:g.232541424_232541425del
  • NG_012954.2:g.6733_6734del
  • NM_005199.5:c.401_402delMANE SELECT
  • NP_005190.4:p.Pro134fs
  • LRG_1275t1:c.401_402del
  • LRG_1275:g.6733_6734del
  • LRG_1275p1:p.Pro134fs
  • NC_000002.11:g.233406134_233406135del
  • NG_012954.1:g.6698_6699del
  • NM_005199.4:c.401_402del
  • NM_005199.4:c.401_402delCT
  • p.Pro134Argfs*43
Protein change:
P134fs
Links:
dbSNP: rs747067203
NCBI 1000 Genomes Browser:
rs747067203
Molecular consequence:
  • NM_005199.5:c.401_402del - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
2

Condition(s)

Name:
Autosomal recessive multiple pterygium syndrome
Synonyms:
MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; Multiple pterygium syndrome Escobar type; Multiple pterygium syndrome nonlethal type; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009926; MedGen: C0265261; Orphanet: 2990; OMIM: 265000

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000590869Molecular Diagnostics Lab, Nemours Children's Health, Delaware
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 4, 2016)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000807223Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Apr 15, 2023)
unknownclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV000996182Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Aug 9, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1not providedclinical testing
not providedunknownyes1not providednot provided1not providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular findings among patients referred for clinical whole-exome sequencing.

Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, Ward P, Braxton A, Wang M, Buhay C, Veeraraghavan N, Hawes A, Chiang T, Leduc M, Beuten J, Zhang J, He W, Scull J, Willis A, Landsverk M, Craigen WJ, Bekheirnia MR, et al.

JAMA. 2014 Nov 12;312(18):1870-9. doi: 10.1001/jama.2014.14601.

PubMed [citation]
PMID:
25326635
PMCID:
PMC4326249

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Molecular Diagnostics Lab, Nemours Children's Health, Delaware, SCV000590869.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyes1not providednot provided1not providednot provided See 1

Co-occurrences

#ZygosityAllelesNumber of Observations
1NM_005199.4:c.250G>A

From Baylor Genetics, SCV000807223.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego, SCV000996182.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

This frameshifting variant in exon 5 of 12 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function. This variant has been previously reported as a homozygous change in patients with Escobar Variant Multiple Pterygium Syndrome (EVMPS) (PMID: 16826531, 27245440). This alteration is present in the gnomAD population database at a frequency of 0.0079% (22/277144) and thus is presumed to be rare. Based on the available evidence, the c.401_402delCT (p.Pro134ArgfsTer43) variant is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024